BioMarin officer plans $1.16M stock sale

Officer George Eric Davis has filed a Rule 144 notice to sell up to 17,557 BioMarin common shares from recent restricted stock vesting.

Rhea-AI Filing Summary

BIOMARIN PHARMACEUTICAL INC (BMRN) has a notice of proposed sale of common stock under Rule 144 filed on behalf of officer George Eric Davis. The filing covers up to 17,557 shares of common stock to be sold through Fidelity Brokerage Services LLC on the NASDAQ market.

The shares relate to restricted stock vesting events of 15,595 shares on March 15, 2026 and 1,962 shares on March 17, 2026, both described as compensation. As of September 2, 2026, 193,573,759 shares of common stock were outstanding, and the proposed sale has an aggregate market value of $1,163,755.77.

Key Figures

Shares proposed for sale: 17,557 shares Aggregate market value of proposed sale: $1,163,755.77 Shares outstanding: 193,573,759 shares +3 more

6 metrics

Shares proposed for sale 17,557 shares Common stock covered by the Rule 144 notice for George Eric Davis

Aggregate market value of proposed sale $1,163,755.77 Value of 17,557 BioMarin common shares in the Form 144

Shares outstanding 193,573,759 shares BioMarin common shares outstanding as of September 2, 2026

Restricted stock vesting (March 15, 2026) 15,595 shares Compensation-related restricted stock vesting from the issuer

Restricted stock vesting (March 17, 2026) 1,962 shares Additional compensation-related restricted stock vesting from the issuer

Trading market NASDAQ Market on which BioMarin common stock is listed for the proposed sale

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact, compensation

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 03/15/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for George E. Davis"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

compensation financial

"15595 | 03/15/2026 | Compensation"

FAQ

What does the Form 144 filing report for BIOMARIN PHARMACEUTICAL INC (BMRN)?

It reports a proposed sale under Rule 144 of up to 17,557 shares of BioMarin common stock for the account of officer George Eric Davis, with the sale to be executed through Fidelity Brokerage Services LLC on NASDAQ.

How many BMRN shares are proposed to be sold and what is their value?

The notice covers 17,557 common shares of BIOMARIN PHARMACEUTICAL INC with an aggregate market value of $1,163,755.77 as reported in the Form 144 filing.

What is the source of the BMRN shares listed in this Form 144?

The shares come from restricted stock vesting described as compensation: 15,595 shares vesting on March 15, 2026 and 1,962 shares vesting on March 17, 2026, all from the issuer.

Who is the person for whose account the BMRN shares will be sold?

The shares are to be sold for the account of George Eric Davis, identified as an officer of BIOMARIN PHARMACEUTICAL INC. The Form 144 is signed by a representative of Fidelity Brokerage Services LLC as attorney-in-fact for him.

How many BioMarin shares were outstanding at the time of this Form 144 notice?

The filing reports that 193,573,759 shares of BIOMARIN PHARMACEUTICAL INC common stock were outstanding as of September 2, 2026, providing context for the size of the proposed Rule 144 sale.

Were any BMRN shares reported as sold in the 3 months prior to this Form 144?

The section for securities sold during the past 3 months contains no entries, indicating no such prior sales are reported in this particular Form 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 02:56 PM Accepted by SEC EDGAR 09/02/2026 - 02:55 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001380710
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BIOMARIN PHARMACEUTICAL INC
SEC File Number	000-26727
Address of Issuer	105 DIGITAL DRIVE NOVATO CALIFORNIA 94949
Phone	4155066700
Name of Person for Whose Account the Securities are To Be Sold	Davis George Eric
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	17557	1163755.77	193573759	09/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2026	Restricted Stock Vesting	Issuer			15595	03/15/2026	Compensation
Common	03/17/2026	Restricted Stock Vesting	Issuer			1962	03/17/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for George E. Davis
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)